Wondering if News on my Favorites page is working??
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No clue. Very disappointing. They had a good niche, but it's been way too long with silence to be a believer any longer. Not to say it's dead, but I chose to move on
Board in progess
Ouch! Someone finally liquidated!
Actually things look pretty darn good! Lawsuit aside, our pipeline is intact & progressing. TLando will still gain full approval next March, partnership news imminent (possibly soon after A/S increase),
1144 results due in a couple months with no bad expectations... yeah I'd say things are looking pretty good!
Anything is possible here
Not yet
You really ought to sell any shares you have in Lipocine if you believe there is any truth to your assessment.
Yep, I'm Sure! There is No RS up for vote.
Nope, no mention whatsoever of any rs vote. Why anyone would get that out of the sec filing last Friday I have no idea. Standard business, they are at roughly 88m os with only 100m as, time to raise the bar just in case.
Hope you & yours are well Cat! Posting here as I think I've got a winner, time will tell. I won't post my due diligence as I'm obviously biased. But it's certainly out there to be found. Lipocine is the company, $LPCN.
Sitting at $1.53 now. I expect many good things in the next 0 thru 14 months!
Anyways, truly do hope you're well!
Vance
Picked up more shares yesterday. I'm surprised there hasn't been any new analyst coverage with the Florida gang overseeing the last offering. I suppose the pending litigation against Clarus is minor cause for concern, but only due to monetary commitments. Regardless of that outcome we're still sitting pretty. TLando will come to market and their pipeline is continuing to advance. All the recent conference exposure has new eyes watching for updates as well. When this heats up, I don't think current prices will be available anymore!
When a catalyst comes as we shareholders believe, I expect we'll see new 1yr+ highs. I honestly can't see how this investment can be a risk at this point. They've got cash, they've gotten tentative fda approval, they've got several other promising candidates! The recent offering is not what I consider dilution. If another one comes without a stated reason then I'll cut & run. But as for now, I'm adding every chance I get!
Assuming the decathlon litigation concludes this year, it may be an end of year write off if nothing else. I have a feeling I'll need it this year!
Current O/S is 88,607,685. Got that number from a Yahoo poster citing O/S values from the offering prospectus and the offering itself. Not bad for where we are at, considering it's still a market cap under 160 million. Company is stronger than ever with several good news press releases at any time. Very safe bet!
Back to $2 and plenty of cash in the coffers! This is Still heading to $3 in the not too distant future and if any of a number of good PR's come out then no holds barred!
Odd they think the stock is under pressure, this was written back in November. We've got good things ahead, this isn't even a bump in the road!
LPCN passed 52wk high today, I'm positive the chart this week shows a Clear uptrend! And I'm no technical chartist ??
Can't blame ya for that, but as steady as it's holding up this morning I'm expecting more is on the horizon!
20k views, 117k subscribers.. yeah I'd say that's cause for end of day volume. Still, as we well know Lipocine is undervalued. There are too many good things out and coming out to ignore.
LPCN BreakOut Imminent!
DD on board:
https://investorshub.advfn.com/Lipocine-Inc-LPCN-28846/
LPCN about to pop!
DD on board:
https://investorshub.advfn.com/Lipocine-Inc-LPCN-28846/
H.C. Wainwright sticks to their Buy rating for LPCN
https://www.analystratings.com/articles/h-c-wainwright-sticks-to-their-buy-rating-for-lipocine-lpcn/
LPCN: LIPOCINE’S LIFT RESULTS: A COMPARISON WITH PEERS
https://news.yahoo.com/lpcn-lipocine-lift-results-comparison-104300871.html
There is literally no risk here, except of dilution. And the chances of that are practically non-existent!
News today is further proof of upper handedness against Clarus.
A number of different scenarios, and the odds of all of them being favorable to Lipocine are high. Hopefully we'll know more next week!
Short sellers have been taunting active LPCN forums for awhile now. They ate up the tentative approval, mistaken web page fiasco. Clarus has much to lose with the upcoming litigation, therefore they likely have a hand in the cookie jar so to speak. Plain English, Clarus shorting hoping LPCN gets strapped for cash & dilutes. Causing further shorting & big profits for those doing it.
Problem is, per the conference call yesterday a TLando distribution partner is imminent and today's news is extremely positive. Non-dilutive funds are not going to be a problem. LPCN is about to be upgraded and shorts will have to cover.
Shorts gotta cover & Clarus likely in the mix. These prices are literally a gift!
LPCN POSITIVE PHASE TWO RESULTS JUST OUT!
https://ir.lipocine.com/
Positive Phase 2 Results just out!
https://ir.lipocine.com/
LPCN POSITIVE PHASE 2 RESULTS JUST OUT!
https://ir.lipocine.com/
Definitely gearing up for an increase in share price soon. Should reach a higher base on any news of TLANDO partnership, Clarus trial, or 1144 phase 2 results. Any other pipeline news is also potential catalysts for increases in share price. This stock is a winner investment right now, just a matter of time before it pays off!
Per the LPCN conference Today:
(Taken from a poster on Yahoo Finance)
1. Commercial partnership discussions are underway and interest has been good. Potential for non-dilutive cash infusion through partnership deal
2. Tlando XR restarts development after Tlando tentative approval. LPCN designing Tlando XR Phase 3 trial
3. They continue to strongly believe that Clarus is infringing on patents, and they hope to prevail with that claim
4. 1144 primary endpoint study to be out in the next few days. Biopsy results to be out in mid 2021. Other data points related to impact on data such as weight, BMI, waist, etc., to be released as the data becomes available prior to mid 2021. Good chance that 1144 will impact these markers
5. If FDA confirms that Makena is out of the market, LPCN 1107 has the potential to become the standard of care.
You can listen via a link from https://ir.lipocine.com/events
Per the conference:
(Taken from a poster on Yahoo Finance)
1. Commercial partnership discussions are underway and interest has been good. Potential for non-dilutive cash infusion through partnership deal
2. Tlando XR restarts development after Tlando tentative approval. LPCN designing Tlando XR Phase 3 trial
3. They continue to strongly believe that Clarus is infringing on patents, and they hope to prevail with that claim
4. 1144 primary endpoint study to be out in the next few days. Biopsy results to be out in mid 2021. Other data points related to impact on data such as weight, BMI, waist, etc., to be released as the data becomes available prior to mid 2021. Good chance that 1144 will impact these markers
5. If FDA confirms that Makena is out of the market, LPCN 1107 has the potential to become the standard of care.
You can listen via a link from https://ir.lipocine.com/events
LPCN LIPOCINE
Keep an eye on this one, about to get interesting with NASH Phase 2 results & More
Of course it did, not unexpected. Clarus chomping at the bit Not to get to trial anyway. Lipocine holding the better hand:
Deal = Win
Trial = Win
My bet is Clarus caves to a cash settlement & withdrawn exclusivity!
Time will tell
Before the trial date in February. It would be in Clarus' best interest for their long term.
I'd expect a settlement